Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Recombinant human N-acetylgalactosamine-6-sulfatase1件: Elosulfase alfa (Recombinant human N-acetylgalactosamine-6-sulfatase)1件: Elosulfase alfa 💬 1件: GALNS 💬 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
2Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS)1件: Elosulfase alfa (Recombinant human N-acetylgalactosamine-6-sulfatase)1件: Elosulfase alfa 💬 1件: GALNS 💬 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
3Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 1101件: Elosulfase alfa (Recombinant human N-acetylgalactosamine-6-sulfatase)1件: Elosulfase alfa 💬 1件: GALNS 💬 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬
4Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 drug substance1件: Elosulfase alfa (Recombinant human N-acetylgalactosamine-6-sulfatase)1件: Elosulfase alfa 💬 1件: GALNS 💬 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19 💬